Latest news with #LexeoTherapeutics
Business Insider
2 days ago
- Business
- Business Insider
Lexeo Therapeutics files to sell 41.63M shares of common stock for holders
16:10 EDT Lexeo Therapeutics (LXEO) files to sell 41.63M shares of common stock for holders Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Business Insider
13-05-2025
- Business
- Business Insider
Lexeo Therapeutics price target lowered to $20 from $22 at Chardan
Chardan analyst Geulah Livshits lowered the firm's price target on Lexeo Therapeutics (LXEO) to $20 from $22 and keeps a Buy rating on the shares. The firm is updating its model following the company's Q1 results, reiterated guidance on its LX2006 and LX2020 programs, as well as its update on its cash position, the analyst tells investors in a research note. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
